uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted March 05, 2021

FTC Takes Further Action Against Deceptive CBD Claims

On March 5, 2021, the Federal Trade Commission (FTC) announced that it has approved final administrative consent orders against six companies for selling CBD products with unsupported and deceptive health claims that they can treat a variety of conditions, including cancer, heart disease, hypertension, Alzheimer's disease, and others. These companies are Bionatrol Health, LLC; Epichouse LLC (First Class Herbalist CBD); CBD Meds, Inc.; HempmeCBD; Reef Industries, Inc.; and Steves Distributing, LLC.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at